COPD

French study extends U.S. findings of disparities in organ access

Real-world data compare two single-inhaler triple therapies

Recent events highlight need for improvement and regulation

Social isolation may lead to fewer resources for managing the condition

Prices went down but reductions in new oxygen prescriptions and discontinuations were minimal

Living in polluted zip codes was linked to worse outcomes after transplant

There remains an unmet need for effective COPD therapies, expert says

Phase III trial program showed 30% to 34% reduction in moderate or severe exacerbations

However, treatment group crossovers muddied the waters in open-label Chinese trial

"We should be cautious about using drugs off-label," investigator says

They'll "still have that ball and chain, but maybe we've lightened it a little bit," says expert

An immediate appointment to a smoking cessation clinic shows benefit versus usual care

Immediate clinical application is unclear, but prototype shows potential

Propellants in metered-dose inhalers are the biggest culprit